Meeder Asset Management Inc Chroma Dex Corp. Transaction History

Meeder Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 02, 2018	SELL	$3.5 - $4.91 $5,232 - $7,340	-1,495 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$3.22 - $4.43 $4,813 - $6,622	1,495 New	1,495 $0
Q1 2018 May 03, 2018	SELL	$4.05 - $6.46 $1,020 - $1,627	-252 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$3.88 - $6.96 $1,649 - $2,958	-425 Reduced 62.78%	252 $1,000
Q3 2017 Oct 20, 2017	BUY	$2.91 - $4.71 $1,970 - $3,188	677	677 $3,000

129

21.9M

203K

23.9K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $370M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.